Unibest 优贝德
← Back to patent-cliff list

CAS 4394-85-8

morpholine-4-carbaldehyde

Codes:PEMIGA-008、VEMF-028

Application context (from source-drug indications)

骨髓瘤佩米替尼淋巴瘤佩米替尼胆管癌佩米替尼胆管上皮癌佩米替尼胆道癌佩米替尼Erdheim-Chester病维罗非尼黑色素瘤维罗非尼组织细胞增生维罗非尼郎格罕细胞组织细胞增生症维罗非尼非霍奇金淋巴瘤维罗非尼肝胚细胞瘤维罗非尼

Source drugs (routes using this intermediate)

DrugTierExpiry
佩米替尼PemigatinibTier C — Watch / trade2032
维罗非尼VemurafenibTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.